ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Medicare Whistleblower Attorney Discusses Michigan Pharmacist Ordered To Pay $1 Million As Settlement For False Claim Act

In a newly released blog post, whistleblower attorney Arvind Bob Khurana discusses a case where a Michigan-based pharmacist is sought to pay $1 Million as settlement for a False Claims Act. The lawyer mentions that the pharmacist Riad Zahr and his two previously-owned pharmacies have agreed to pay $1 Million to resolve allegations of false claims for an anti-overdose drug.

Whistleblower attorney Arvind Bob Khurana also explains that the information was released by the Department of Justice (DOJ) in their press release last December 8, 2021. As part of the settlement, the whistleblower of the case has been awarded $200,000.

whistleblower attorney

In the new blog post, lawyer Arvind Bob Khurana mentions how the pharmacist and his two, previously-owned pharmacies committed the false claims act. The submitted false claims were made between August 1, 2017, and June 30, 2019, for the drug Evzio.

According to Attorney Arvind Khurana, “Evzio (naloxone hydrochloride injection) was the highest-priced version of naloxone drug on the market used to reverse opioid overdose. Due to its price, the insurance companies are required to submit prior authorization requests before approving to cover for Evzio.”

The attorney also explains that in the press release submitted by the DOJ, it is said that both pharmacies of Raid Zahr submitted false and misleading prior authorization requests for Evzio that contained clinical assertions for which the pharmacies lacked any factual basis.

Furthermore, it is said on the blog post that the $1 Million is to resolve DOJ’s claim that the two pharmacies initiated Evzio prescriptions based on rudimentary patient lists with only basic biographical details.

Additionally, the lawyer mentions that the allegations were first brought up by Ms. Rebecca Socol, who formerly worked for the manufacturer of Evzio, kaléo Inc. She will be rewarded $200,000 of the settlement amount for her involvement and the provided information which led to the case. Also in 2021, Mrs. Socol already received $2,548,600 for the information she gave about kaléo Inc. she worked for which allegedly “caused the submission of false claims” for Evzio.

Lastly, Attorney Bob Khurana encourages people to help the government track these illegal processes down. He explains that whistleblowers are the first line of defense in the government’s fight against fraudulent claims.


About Whistleblower Attorney Arvind Bob Khurana

Whistleblower lawyer Arvind Khurana is a national lawyer for whistleblowers and he aids individuals in constructing a solid case. The whistleblower attorney has assisted whistleblowers in receiving an award for their efforts in combating fraud. He also has a team of whistleblower lawyers at Khurana Law Firm P.C. who support a client’s decision to come forward to reveal fraudulent activities and abuse within the health care sector. Contact them today to schedule a consultation or visit https://medicarewhistleblowercenter.com/pharmacist-and-two-pharmacies-to-pay-1-million-false-claims-act-settlement/ to learn more.

https://www.youtube.com/watch?v=K1W-GxNGxkU&t=5s&ab_channel=KhuranaLawFirm%2CP.C.

###

For more information about Khurana Law Firm, P.C. | Medicaid and Medicare Whistleblower Attorney , contact the company here:

Khurana Law Firm, P.C. | Medicaid and Medicare Whistleblower Attorney
Arvind Bob Khurana
(888) 335-5107
akhurana@khuranapc.com
116 W 23rd St 5th floor, New York, NY 10011, United States

FacebookTwitterGoogleDiggRedditLinkedIn

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.